AstraZeneca subpoenaed
Executive Summary
The Boston U.S. Attorney's office issues subpoena to AstraZeneca as part of an investigation related to sales and marketing practices to a physician's office in Worcester, Mass., company says in a Securities & Exchange Commission 1filing. This investigation is separate from another Boston U.S. Attorney investigation into Prilosec promotions to New England Medical Center (2"The Pink Sheet" March 3, 2003, p. 3)...
You may also be interested in...
AstraZeneca Nexium Marketing Draws FTC Scrutiny; DoJ Looking At Prilosec
The Federal Trade Commission is investigating AstraZeneca's marketing of the omeprazole follow-on product Nexium
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.